Acceleron Pharma Inc
XLRNDelisted Nov 22, 2021- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001280600
Acceleron Pharma Inc was delisted on Nov 22, 2021; its insiders filed their last Form 4 on Nov 22, 2021; 333 institutions reported holding it in 13F filings for Q3 2021, worth $9.22B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Acceleron Pharma Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 271 | 2 | 333 | +64 |
| Shares | 54.0M | 671.1K | 53.6M | +215.8K (+0.4%) |
| Value | $6.78B | $84.2M | $9.22B | +$2.52B (+37.7%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (99)
Institutions that held Acceleron Pharma Inc at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (35)
Institutions that held Acceleron Pharma Inc at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (2)
Institutions that held Acceleron Pharma Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 671,041 | $84.2M |
| CWM, LLC | 21 | $3.00K |